Reuters UK
NEW YORK, Dec 2 (Reuters) - Shares of Bank of America Corp (BAC.N) rose 3.2 percent after the close on Wednesday after it said it has worked out a deal with ...
and more »
Welcome to my new trading blog based of after hours stocks. Please subscribe for updates.
Bank of America Corporation (NYSE: BAC) is almost always one of the most active call options stocks out there. But today we are seeing a flurry of trading activity based upon last night’s announcement that it is repaying the full TARP amount. This first list is the DEC-2009 CALLS and we followed it with DEC-2009 PUTS as well:
CALL$   Volume   OpInt
$15.00Â Â Â 10,711Â Â Â 37,503
$16.00Â Â Â 99,716Â Â Â 102,460
$17.00Â Â Â 62,006Â Â Â 109,868
$18.00 Â Â Â 16,721Â Â Â 84,740
$19.00Â Â Â 3,041Â Â Â 20,268
$20.00Â Â Â 1,849Â Â Â 12,537
PUT$   Volume   OpInt
$14.00Â Â Â 2,933Â Â Â 104,680
$15.00Â Â Â 23,208Â Â Â 104,484
$16.00Â Â Â 74,628Â Â Â 84,786
$17.00Â Â Â 97,617Â Â Â 37,044
The stock is up 2.5% at $16.04 on the reactio to last night’s news. At 12:05 PM EST we have already more than doubled the average volume with about 374 million shares trading hands…. 4 hours to go.
JON C. OGG
DECEMBER 3, 2009
Huntsman Corporation (NYSE: HUN) is seeing a surge in options activity. There have been 30,698 calls traded, 15X average, and implied volatility is spiking 44% on rumors that Dupont (NYSE: DD) is looking at a possible $18 offer for shares of the company. The action has been extremely bullish with block buyers in calls at the offer ahead of the rumor and continuing now in strikes as high as the January $13 calls. Shares trade 1.45X cash value and look very cheap on valuation.
This deal appears to fit in with some deals of the past and it is worth noting that Huntsman was a busted private equity acquisition where Hexion Specialty Chemicals was originally going to acquire the company for about $28.00 per share. Shares are also up almost 8% at $10.70 and the 4.5 million share average volume has now been crossed at 11:25 AM EST.
Joe Kunkle, OptionsHawk.com
Geron Corporation (NASDAQ: GERN), StemCells Inc. (NASDAQ: STEM), and Opexa Therapeutics, Inc. (NASDAQ: OPXA) are all playing give-back this morning on the heels of monster gains yesterday due to the National Institutes of Health approving new embryonic stem cell lines.
At 8:39 AM EST we have GERN down 2.9% at $6.02 on 80,000 shares, STEM down 5.4% at $1.40 on 695,000 shares, and OPXA is down 10% at $2.86 on 35,000 shares. As a reminder, the NIH did say that it would be making a new announcement on stem cell line approvals after 96 lines were submitted…. and that deadline is tomorrow, so these may all swing wildly yet again.
JON C. OGG